Scoring Systems for Estimating Risk of Venous Thromboembolism in Hospitalized Medical Patients

被引:25
作者
Barbar, Sofia [1 ]
Prandoni, Paolo [2 ]
机构
[1] Azienda Ulss 15 Alta Padovana, Dept Med, Via Casa Ricovero 40, I-35013 Padua, Italy
[2] Univ Padua, Dept Cardiovasc Sci, Padua, Italy
关键词
medical inpatients; venous thromboembolism; thromboprophylaxis; risk assessment model; scoring systems; DEEP-VEIN THROMBOSIS; PREVENTION REGISTRY; PULMONARY-EMBOLISM; ASSESSMENT MODEL; BLEEDING RISK; PROPHYLAXIS; VALIDATION; INPATIENTS; PLACEBO; VTE;
D O I
10.1055/s-0036-1597901
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deep vein thrombosis and pulmonary embolism are associated with considerable morbidity and mortality in hospitalized patients, accounting for up to 10% of hospitalization-related deaths in both surgical and medical patients. Pharmacologic thromboprophylaxis has been demonstrated to be effective, safe, and cost-effective in preventing hospital-acquired venous thromboembolism (VTE) among medical inpatients, and clinician awareness of thrombotic risk promotes prescription of thromboprophylaxis. Guidelines recommend stratification of thrombotic risk for all patients and, unless contraindicated, administration of VTE prophylaxis. Based on several recognized predisposing and exposing risk factors for VTE, several scoring systems have been published in the past 15 years. Borrowing models developed in the surgical setting, recognized risk factors for VTE complications in medical inpatients have been combined in different weighted scores and derived and validated in heterogeneous medical populations. Although the perfect score, balancing thrombotic and hemorrhagic risk, has probably not yet been built, the adoption of an easy-to-use risk assessment model has the potential to support physicians in properly stratifying VTE risk in medical inpatients, tailoring thromboprophylaxis prescription.
引用
收藏
页码:460 / 468
页数:9
相关论文
共 47 条
[1]   Prevention of in-hospital VTE: why can't we do better? [J].
Ageno, Walter ;
Dentali, Francesco .
LANCET, 2008, 371 (9610) :361-362
[2]   Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study [J].
Alikhan, R ;
Cohen, AT ;
Combe, S ;
Samama, MM ;
Desjardins, L ;
Eldor, A ;
Janbon, C ;
Leizorovicz, A ;
Olsson, CG ;
Turpie, AGG .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :963-968
[3]  
ARCELUS JI, 1991, SEMIN THROMB HEMOST, V17, P313
[4]   A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score [J].
Barbar, S. ;
Noventa, F. ;
Rossetto, V. ;
Ferrari, A. ;
Brandolin, B. ;
Perlati, M. ;
De Bon, E. ;
Tormene, D. ;
Pagnan, A. ;
Prandoni, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) :2450-2457
[5]  
CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304
[6]   Identifying acutely ill medical patients requiring thromboprophylaxis [J].
Chopard, P ;
Spirk, D ;
Bounameaux, H .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) :915-916
[7]   Venous thromboembolism prophylaxis in acutely ill medical patients:: definite need for improvement [J].
Chopard, P ;
Dörffler-Melly, J ;
Hess, U ;
Wuillemin, WA ;
Hayoz, D ;
Gallino, A ;
Bachli, EB ;
Canova, CR ;
Isenegger, J ;
Rubino, R ;
Bounameaux, H .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (04) :352-357
[8]   Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study [J].
Cohen, Alexander T. ;
Tapson, Victor F. ;
Bergmann, Jean-Francois ;
Goldhaber, Samuel Z. ;
Kakkar, Ajay K. ;
Deslandes, Bruno ;
Huang, Wei ;
Zayaruzny, Maksim ;
Emery, Leigh ;
Anderson, Frederick A., Jr. .
LANCET, 2008, 371 (9610) :387-394
[9]   Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial [J].
Cohen, AT ;
Davidson, BL ;
Gallus, AS ;
Lassen, MR ;
Prins, MH ;
Tomkowski, W ;
Turpie, AGG ;
Egberts, JFM ;
Lensing, AWA .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7537) :325-327
[10]   Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients [J].
Cohen, AT ;
Alikhan, R ;
Arcelus, JI ;
Bergmann, JF ;
Haass, S ;
Merli, G ;
Spyropoulos, AC ;
Tapson, VF ;
Turpie, AGG .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) :750-759